本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Mersana Therapeutics Inc.

0.3168
-0.0482-13.21%
盤後0.33180.0150+4.73%19:58 EDT
成交量:227.53萬
成交額:73.89萬
市值:3,948.32萬
市盈率:-0.56
高:0.3550
開:0.3550
低:0.3110
收:0.3650
資料載入中...
2021/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report
2021/04/09

重要事件披露

8-K - Current report
2021/03/11

重要事件披露

8-K - Current report
2021/02/26

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/26

重要事件披露

8-K - Current report
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/27

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/25

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/12

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/05

重要事件披露

8-K - Current report
2020/12/10

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/30

重要事件披露

8-K - Current report
2020/11/19

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/09

重要事件披露

8-K - Current report
2020/09/22

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership